VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ORKA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ORKAOruka Therapeutics, Inc.
$95.74$5.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksORKAQuarterly Cash Flow

Oruka Therapeutics, Inc. (ORKA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Oruka Therapeutics, Inc. (ORKA) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

ORKA Cash Flow Statement

Quarterly statement

ORKA Cash Flow Statement

Oruka Therapeutics, Inc. (ORKA) cash flow statement — 21-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20
Cash from Operations-44.33M-33.15M-23.58M-22.59M-21.6M-23.14M-20.87M-18.82M-34.86M-2.63M-168K--4.3M-4.95M-4.87M-3.72M-5.22M-3M-2M-1.04M
Operating CF Margin %--------------------
Operating CF Growth %-105.19%-43.21%-12.98%-20.07%38.03%-778.7%-12322.02%-----17.74%-65.18%-143.26%-257.01%-209.91%-158.64%-125.7%12.44%
Net Income-49.97M-41.21M-31.82M-29.58M-30.28M-24.57M-21M-25.78M-28.62M-2.68M-7.08M--3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.3M
Depreciation & Amortization49K43K43K28K20K19K16K16K012K6.86M-28K28K27K19K17K16K26K26K
Stock-Based Compensation9.13M00010.16M5.08M4.88M00085K-00000000
Deferred Taxes00000000000-00000000
Other Non-Cash Items-1.81M6.48M6.67M3.59M-908K-1.38M-1.74M2.97M-13.58M112K-6.86M-169K119K104K133K141K18K5K4K
Working Capital Changes-1.73M1.54M1.53M3.37M-602K-2.29M-3.03M3.98M7.34M-80K6.82M--1.22M582K-289K962K-1.28M2.1M-42K230K
Change in Receivables00000000001K-00000000
Change in Inventory00000000000-00000000
Change in Payables6.43M4.29M-493K1.95M-2.57M421K83K1.84M1.41M05.83M--103K-6K-1.07M605K56K1.02M186K190K
Cash from Investing-159.4M-410.95M-14.44M-22.02M-122.45M4.86M42.87M-329.96M-171K00--2K-7K-14K-16K-6K-13K0-3K
Capital Expenditures-83K0-73K-63K-99K-34K-13K-18K-171K00--2K-7K-14K-16K-6K-13K0-3K
CapEx % of Revenue--------------------
Acquisitions00000000000-00000000
Investments--------------------
Other Investing0000-122.35M00-329.94M000-00000000
Cash from Financing126.77M663.04M40.6M298K169.91M109K0-526K450.05M14K27.91M-000023.09M984K42.06M5.41M
Debt Issued (Net)000000000024.98M-00000-137K-136K-135K
Equity Issued (Net)126.77M663.04M40.6M298K0109K029.39M420.13M14K2.93M-000023.09M1.12M42.19M5.55M
Dividends Paid00000000000-00000000
Share Repurchases00000000000-00000000
Other Financing0000169.91M00-29.92M29.92M00-00000000
Net Change in Cash-76.95M218.95M2.58M-44.32M25.86M-18.18M22M-349.3M377.59M-2.62M27.74M--4.3M-4.95M-4.88M-3.74M17.86M-2.02M40.05M4.37M
Free Cash Flow-44.41M-33.15M-23.65M-22.66M-21.7M-23.18M-20.88M-18.84M-35.03M-2.63M-168K--4.3M-4.95M-4.88M-3.74M-5.23M-3.01M-2M-1.04M
FCF Margin %--------------------
FCF Growth %-104.64%-43%-13.26%-20.29%38.05%-779.99%-12329.76%-----17.8%-64.69%-143.96%-257.51%-209.71%-159.31%-125.2%12.19%
FCF per Share-0.62-0.53-0.43-0.42-0.49-0.55-0.50-1.12-2.33-0.18-0.01--3.58-4.13-4.07-3.11-5.08-3.78-3.97-6.99
FCF Conversion (FCF/Net Income)0.89x0.80x0.74x0.76x0.71x0.94x0.99x0.56x1.22x0.12x0.08x-1.31x0.87x1.03x0.77x1.27x0.58x1.01x0.80x
Interest Paid00000000000-00000000
Taxes Paid00000000000-00000000